Correction to: Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs

The authors apologized for the unfortunate error in figure during publication of the article and they also explained that some of the solid grey graphs in Fig. 5 are intentionally based on the same data. For 8 different surface makers (CD14, CD73, CD34, CD105, CD19, CD90, CD45, HA-DR) in accordance...

Full description

Saved in:
Bibliographic Details
Main Authors: Nold, Philipp (Author) , Jungebluth, Philipp (Author)
Format: Article (Journal)
Language:English
Published: 17 September 2019
In: Journal of nanobiotechnology
Year: 2019, Volume: 17, Issue: 1, Pages: 98
ISSN:1477-3155
DOI:10.1186/s12951-019-0527-6
Online Access:Verlag, Volltext: https://doi.org/10.1186/s12951-019-0527-6
Get full text
Author Notes:Philipp Nold, Raimo Hartmann, Neus Feliu, Karsten Kantner, Mahmoud Gamal, Beatriz Pelaz, Jonas Hühn, Xing Sun, Philipp Jungebluth, Pablo del Pino, Holger Hackstein, Paolo Macchiarini, Wolfgang J. Parak and Cornelia Brendel
Description
Summary:The authors apologized for the unfortunate error in figure during publication of the article and they also explained that some of the solid grey graphs in Fig. 5 are intentionally based on the same data. For 8 different surface makers (CD14, CD73, CD34, CD105, CD19, CD90, CD45, HA-DR) in accordance to the guidelines of the manufacturer a panel of 4 different isotype controls were used, corresponding to 4 different fluorescence channels.
Item Description:Gesehen am 04.12.2019
Physical Description:Online Resource
ISSN:1477-3155
DOI:10.1186/s12951-019-0527-6